Share this page

Twitter Facebook
The Global Fund / John Rae

The Global Fund strategy is a multi-year roadmap for the partnership’s future. The strategy sets out priorities for how the Global Fund partnership can accelerate progress against HIV, TB and malaria and improve global health. It also includes ambitious goals and targets to measure progress.

The Global Fund Strategy 2017-2022

The Global Fund Strategy 2017-2022: Investing to End Epidemics outlines our partnership’s bold agenda for 2017-2022 based on an ambitious vision to end the epidemics. These four strategic objectives are at the core of the strategy:

Each strategic objective is each underpinned by a number of sub-objectives and supported by two strategic enablers. These objectives provide a critical path outlining how the Global Fund will work with partners to ensure that the response globally and at country level is inclusive, impactful and sustainable. Progress on implementation of our strategy is measured through key performance indicators and undertaken at all levels of the Global Fund partnership.

The Global Fund Strategy 2017-2022: Investing to End Epidemics
download in English

Download the full Global Fund Strategy 2017-2022 for a detailed look at our objectives and key performance indicators as well as how the strategy links to achievement of the Sustainable Development Goals.


The strategy’s performance targets call for programs supported by the Global Fund to save 14 million lives in the three-year period beginning in 2017, bringing the total lives saved by the Global Fund partnership to 36 million by the end of 2019. Those programs will also avert up to 194 million new infections or cases of HIV, TB and malaria. Global Fund support will further catalyze US$35 billion in domestic finance for health and drive US$230 billion in economic gains.

Projections show that every US$100 million invested in Global Fund-supported programs will:

  • Save 133,000 lives through programs supported by the Global Fund, and;
  • Avert 1.9 million new infections or cases across the three diseases, and;
  • Spur domestic investment of US$300 million toward the three diseases, and;
  • Create US$2.2 billion in long-term economic gains, and;
  • Provide antiretroviral therapy for 107,000 people, and;
  • Provide treatment for 31,000 women to prevent passing HIV to their babies, and;
  • Provide TB treatment and care for 153,000 people, and;
  • Provide 4,300 people with treatment for multidrug-resistant TB, and;
  • Distribute 6.2 million mosquito nets to protect children and families from malaria, and;
  • Provide indoor residual spraying for 1.2 million households to protect children and families from malaria.


The current strategy was developed through an extensive consultation process in 2014-2015 that collected the strongest ideas, perspective and guidance. The consultations included three regional Partnership Forums with over 300 participants from 128 countries, a 12-week consultation with over 1,200 participants from 143 countries, and dozens of focused meetings and consultations on specific aspects of the strategy. The strategy development process captured the expertise, diversity and innovative spirit of the Global Fund Board, and integrated broader views and experience of partners.

Themes that emerged from the consultations included the need to better address challenges faced by women and girls; the need to support resilient and sustainable systems for health; and the need to strengthen work on sustainability and human rights.

The Board unanimously approved the strategy in April 2016. The Board approved the performance targets in March 2017.

Published 06 November 2017